Proinflammatory cytokines regulate antigen independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients

被引:47
作者
Martino, G
Grohovaz, F
Brambilla, E
Codazzi, F
Consiglio, A
Clementi, E
Filippi, M
Comi, G
Grimaldi, LME
机构
[1] Univ Milan, San Raffaele Sci Inst, Neuroimmunol Unit, DIBIT,Dept Neurol, I-20132 Milan, Italy
[2] Univ Milan, San Raffaele Sci Inst, CNR Cytopharmacol Ctr,Dept Pharmacol, Neurophysiol Unit,DIBIT, I-20132 Milan, Italy
[3] Univ Milan, San Raffaele Sci Inst, B Ceccareli Ctr, I-20132 Milan, Italy
[4] Univ Milan, San Raffaele Sci Inst, Dept Neurol, I-20132 Milan, Italy
[5] Univ Reggio Calabria, Fac Pharm, Chair Pharmacol, Catanzaro, Italy
关键词
D O I
10.1002/ana.410430312
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Central nervous system (CNS) lesions typical of multiple sclerosis (MS) are characterized by demyelinating inflammatory infiltrates that contain few CNS antigen-specific autoreactive T cells and a multitude of pathogenic non-antigen-specific mononuclear cells. Here, we report that in patients with MS the combined action of interferon-gamma (IFN gamma), tumor necrosis factor-alpha (TNF alpha), interleukin (IL)-2, and IL-6 leads to the activation of most peripheral T cells (mainly CD4 memory) by promoting a persistent intracellular calcium increase via two independent signaling pathways. The activation of these pathways, one activated by IFN gamma and the other by the combination TNF alpha/IL-2/IL-6, is independent from myelin antigens and precedes by 2 weeks phases of disease activity (eg, clinical relapses and/or appearance of gadolinium-enhancing lesions on brain magnetic resonance imaging scans during 1 year of follow-up). Our results indicate that an appropriate combination of the four cytokines, three with a proinflammatory profile and one necessary for T-cell growth and differentiation, can activate in an antigen-independent fashion most peripheral T cells from MS patients. This mechanism is likely to contribute to the recruitment of nonspecific lymphocytes into the cellular activation processes leading to CNS demyelination and may represent a major target for immune intervention in MS.
引用
收藏
页码:340 / 349
页数:10
相关论文
共 34 条
[1]   INCREASED PRODUCTION OF INTERFERON GAMMA AND TUMOR NECROSIS FACTOR PRECEDES CLINICAL MANIFESTATION IN MULTIPLE-SCLEROSIS - DO CYTOKINES TRIGGER OFF EXACERBATIONS [J].
BECK, J ;
RONDOT, P ;
CATINOT, L ;
FALCOFF, E ;
KIRCHNER, H ;
WIETZERBIN, J .
ACTA NEUROLOGICA SCANDINAVICA, 1988, 78 (04) :318-323
[2]   CHRONIC EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS PRODUCED BY BOVINE PROTEOLIPID APOPROTEIN - IMMUNOLOGICAL STUDIES IN RABBITS [J].
CAMBI, F ;
LEES, MB ;
WILLIAMS, RM ;
MACKLIN, WB .
ANNALS OF NEUROLOGY, 1983, 13 (03) :303-308
[3]  
CLEMENTI E, 1995, MOL PHARMACOL, V47, P517
[4]  
CLEMENTI E, 1992, J BIOL CHEM, V267, P2164
[5]   TRANSGENIC MICE THAT EXPRESS A MYELIN BASIC PROTEIN-SPECIFIC T-CELL RECEPTOR DEVELOP SPONTANEOUS AUTOIMMUNITY [J].
GOVERMAN, J ;
WOODS, A ;
LARSON, L ;
WEINER, LP ;
HOOD, L ;
ZALLER, DM .
CELL, 1993, 72 (04) :551-560
[6]   CEREBELLAR GRANULE NEURONS DEVELOP ELEVATED CALCIUM RESPONSES WHEN TREATED WITH INTERLEUKIN-6 IN CULTURE [J].
HOLLIDAY, J ;
PARSONS, K ;
CURRY, J ;
LEE, SY ;
GRUOL, DL .
BRAIN RESEARCH, 1995, 673 (01) :141-148
[7]   CORRELATION BETWEEN MAGNETIC-RESONANCE-IMAGING FINDINGS AND LESION DEVELOPMENT IN CHRONIC, ACTIVE MULTIPLE-SCLEROSIS [J].
KATZ, D ;
TAUBENBERGER, JK ;
CANNELLA, B ;
MCFARLIN, DE ;
RAINE, CS ;
MCFARLAND, HF .
ANNALS OF NEUROLOGY, 1993, 34 (05) :661-669
[8]   Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration [J].
Khan, OA ;
Xia, Q ;
Bever, CT ;
Johnson, KP ;
Panitch, HS ;
DhibJalbut, SS .
NEUROLOGY, 1996, 46 (06) :1639-1643
[9]   HIGH-INCIDENCE OF SPONTANEOUS AUTOIMMUNE ENCEPHALOMYELITIS IN IMMUNODEFICIENT ANTIMYELIN BASIC-PROTEIN T-CELL RECEPTOR TRANSGENIC MICE [J].
LAFAILLE, JJ ;
NAGASHIMA, K ;
KATSUKI, M ;
TONEGAWA, S .
CELL, 1994, 78 (03) :399-408
[10]   POTASSIUM AND CALCIUM CHANNELS IN LYMPHOCYTES [J].
LEWIS, RS ;
CAHALAN, MD .
ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 :623-653